Health-related quality of life in patients with bronchiolitis obliterans

被引:3
作者
Atag, Emine [1 ]
Ikizoglu, Nilay Bas [2 ]
Ergenekon, Pinar [2 ]
Kalin, Sevinc [3 ]
Unal, Fusun [4 ]
Gokdemir, Yasemin [2 ]
Eralp, Ela Erdem [2 ]
Yalcin, Koray [5 ]
Oktem, Sedat [1 ]
Ersu, Refika [2 ]
Karakoc, Fazilet [2 ]
Karadag, Bulent [2 ]
机构
[1] Medipol Univ, Fac Med, Div Pediat Pulmonol, Istanbul, Turkey
[2] Marmara Univ, Fac Med, Div Pediat Pulmonol, Istanbul, Turkey
[3] Umraniye Training & Res Hosp, Dept Pediat Radiol, Istanbul, Turkey
[4] Medipol Univ, Fac Med, Dept Pediat Istanbul, Istanbul, Turkey
[5] Med Pk Hosp, Pediat Stem Cell Transplantat Unit, Istanbul, Turkey
关键词
bronchiolitis obliterans; children; quality of life; VERSUS-HOST-DISEASE; CYSTIC-FIBROSIS; CELL TRANSPLANTATION; CHILDREN;
D O I
10.1002/ppul.24896
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Introduction Bronchiolitis obliterans (BO) is mainly caused by infections and hematopoietic stem cell transplantation (HSCT). This study aimed to investigate the health-related quality of life (HRQOL) of children with BO compared to the healthy children and also to assess the HRQOL according to the etiology. Methods Postinfectious (group 1) and post-HSCT BO (group 2) patients and healthy children were included in the study. HRQOL was assessed by the Short Form-36 (SF-36) and St George's Respiratory Questionnaire (SGRQ). Correlations between demographic and clinical characteristics, pulmonary function tests, high-resolution chest tomography scores, and HRQOL were assessed. Results Thirty-seven postinfectious and post-HSCT BO patients and 34 healthy children were included in the study. Mean age was 13.8 +/- 0.7 years. Mean forced vital capacity and forced expiratory volume(1)were 60.7 +/- 2.7% predicted, and 49.8 +/- 3.1% predicted, respectively. The SF-36 scores were lower in BO patients compared to healthy children (P < .01). Patients with better lung functions had higher SF-36 scores, but lower SGRQ. The number of inhaled therapies, acute exacerbations, hospitalizations were inversely correlated with SF-36. A positive correlation was found between these parameters and total SGRQ scores (r = .507,P = .02;r = .409,P = .12;r = .326,P = .049, respectively). SF-36 scores were better in group 1 for subscales of physical role functioning and social role functioning compared to group 2. (P = .01,P = .01, respectively). Conclusion The HRQOL of patients with BO measured by SF-36 was low compared to healthy children. SF-36 scores were more affected in post-HSCT BO patients. HRQOL of children with chronic lung disease should be taken into consideration in the management of these patients.
引用
收藏
页码:2361 / 2367
页数:7
相关论文
共 27 条
[1]   Health-related quality of life in patients who develop bronchiolitis obliterans syndrome following allo-SCT [J].
Amin, E. N. ;
Phillips, G. S. ;
Elder, P. ;
Jaglowski, S. ;
Devine, S. M. ;
Wood, K. L. .
BONE MARROW TRANSPLANTATION, 2015, 50 (02) :289-295
[2]   The relationship between psychological symptoms, lung function and quality of life in children and adolescents with non-cystic fibrosis bronchiectasis [J].
Bahali, Kayhan ;
Gedik, Ahmet Hakan ;
Bilgic, Ayhan ;
Cakir, Erkan ;
Kahraman, Feyza Ustabas ;
Osmanoglu, Nurcan Keskin ;
Uzuner, Selcuk ;
Kilicoglu, Ali Guven .
GENERAL HOSPITAL PSYCHIATRY, 2014, 36 (05) :528-532
[3]   CYSTIC-FIBROSIS - SCORING SYSTEM WITH THIN-SECTION CT [J].
BHALLA, M ;
TURCIOS, N ;
APONTE, V ;
JENKINS, M ;
LEITMAN, BS ;
MCCAULEY, DI ;
NAIDICH, DP .
RADIOLOGY, 1991, 179 (03) :783-788
[4]   Postinfectious bronchiolitis obliterans in children: the South American contribution [J].
Castro-Rodriguez, Jose A. ;
Giubergia, Veronica ;
Fischer, Gilberto B. ;
Castanos, Claudio ;
Sarria, Edgar E. ;
Gonzalez, Ramiro ;
Mattiello, Rita ;
Vega-Briceno, Luis E. ;
Murtagh, Patricia .
ACTA PAEDIATRICA, 2014, 103 (09) :913-921
[5]   Impact of chronic graft-versus-host disease on the health status of hernatopoietic cell transplantation survivors: a report from the Bone Marrow Transplant Survivor Study [J].
Fraser, Christopher J. ;
Bhatia, Smita ;
Ness, Kirsten ;
Carter, Andrea ;
Francisco, Liton ;
Arora, Mukta ;
Parker, Pablo ;
Forman, Stephen ;
Weisdorf, Daniel ;
Gurney, James G. ;
Baker, K. Scott .
BLOOD, 2006, 108 (08) :2867-2873
[6]   Long-term health-related quality of life and walking capacity of lung recipients with and without bronchiolitis obliterans syndrome [J].
Gerbase, Margaret W. ;
Soccal, Paola M. ;
Spiliopoulos, Anastase ;
Nicod, Laurent P. ;
Rochat, Thierry .
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2008, 27 (08) :898-904
[7]   Quality of Life in Children with Non-Cystic-Fibrosis Bronchiectasis [J].
Gokdemir, Yasemin ;
Hamzah, Ameer ;
Erdem, Ela ;
Cimsit, Cagatay ;
Ersu, Refika ;
Karakoc, Fazilet ;
Karadag, Bulent .
RESPIRATION, 2014, 88 (01) :46-51
[8]   Six-minute walk, lung clearance index, and QOL in bronchiolitis obliterans and cystic fibrosis [J].
Gur, Michal ;
Masarweh, Kamal ;
Toukan, Yazeed ;
Nir, Vered ;
Bar-Yoseph, Ronen ;
Hanna, Moneera ;
Manor, Eynav ;
Hakim, Fahed ;
Bentur, Lea .
PEDIATRIC PULMONOLOGY, 2019, 54 (04) :451-456
[9]   National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report [J].
Jagasia, Madan H. ;
Greinix, Hildegard T. ;
Arora, Mukta ;
Williams, Kirsten M. ;
Wolff, Daniel ;
Cowen, Edward W. ;
Palmer, Jeanne ;
Weisdorf, Daniel ;
Treister, Nathaniel S. ;
Cheng, Guang-Shing ;
Kerr, Holly ;
Stratton, Pamela ;
Duarte, Rafael F. ;
McDonald, George B. ;
Inamoto, Yoshihiro ;
Vigorito, Afonso ;
Arai, Sally ;
Datiles, Manuel B. ;
Jacobsohn, David ;
Heller, Theo ;
Kitko, Carrie L. ;
Mitchell, Sandra A. ;
Martin, Paul J. ;
Shulman, Howard ;
Wu, Roy S. ;
Cutler, Corey S. ;
Vogelsang, Georgia B. ;
Lee, Stephanie J. ;
Pavletic, Steven Z. ;
Flowers, Mary E. D. .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2015, 21 (03) :389-401
[10]   A SELF-COMPLETE MEASURE OF HEALTH-STATUS FOR CHRONIC AIR-FLOW LIMITATION - THE ST-GEORGES RESPIRATORY QUESTIONNAIRE [J].
JONES, PW ;
QUIRK, FH ;
BAVEYSTOCK, CM ;
LITTLEJOHNS, P .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1992, 145 (06) :1321-1327